| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/08/2004 | CN1527836A Antiviral agents for treatment of flaviviridae infections |
| 09/08/2004 | CN1527831A Antagonists of MCP-q function and method of use thereof |
| 09/08/2004 | CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes |
| 09/08/2004 | CN1527828A 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/08/2004 | CN1527824A Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
| 09/08/2004 | CN1527814A Nitric oxide synthase inhibitor phosphate salt |
| 09/08/2004 | CN1527723A Methods for treating or preventing skin disorders using CD2-binding agents |
| 09/08/2004 | CN1527710A Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/08/2004 | CN1527697A Immune modulation device for use in animals |
| 09/08/2004 | CN1526444A Composition for immunological activation |
| 09/08/2004 | CN1526433A Compound American ginseng prepn and its prepn process |
| 09/08/2004 | CN1526422A Composition with functions of regulating immunity and resisting fatigue and its prepn, use and quality control method |
| 09/08/2004 | CN1526392A Cetirizine hydrochloride guttate pills and the prepn |
| 09/08/2004 | CN1526390A Piduomode granule and its prepn |
| 09/08/2004 | CN1165545C Method for separating and extracting total flavone from goldenrain tree plant and its application |
| 09/08/2004 | CN1165522C Bradykinin receptor antagonists |
| 09/08/2004 | CN1165319C Elmus flower belong to Holland elm and its extracts and use in preparation of reverse transcriptase inhibitor |
| 09/08/2004 | CN1165310C Drug-(combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6- enoic acid and an inhibitor,inducer or substrate of P450 |
| 09/07/2004 | US6787653 Reacting, in the presence of a metal catalyst, a halogenobenzoic acid derivative with benzene derivative to produce biphenyldicarboxylic acid amide derivative |
| 09/07/2004 | US6787634 Recognizes the extracellular domain of the human ifn-r and which has neutralizing capacity against the biological properties of human type i-ifn. |
| 09/07/2004 | US6787554 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives |
| 09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
| 09/07/2004 | US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
| 09/07/2004 | US6787536 Hydroxamic acid derivatives |
| 09/07/2004 | US6787532 Formulation containing anti-inflammatory androstane derivatives |
| 09/07/2004 | US6787521 Skin disorders; kidney and liver disorders |
| 09/03/2004 | CA2456410A1 Stabilised pharmaceutical composition comprising an extented release non-steroidal anti-inflammatory agent and an immediate release prostaglandin |
| 09/02/2004 | WO2004074323A1 Idiotypic vaccine |
| 09/02/2004 | WO2004074322A1 Modified soluble t cell receptor |
| 09/02/2004 | WO2004074297A1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators |
| 09/02/2004 | WO2004074260A1 Pyrimidine derivatives |
| 09/02/2004 | WO2004074240A1 Prostaglandin derivatives |
| 09/02/2004 | WO2004074224A1 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 09/02/2004 | WO2004073736A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 09/02/2004 | WO2004073728A2 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 09/02/2004 | WO2004073701A1 Lfa-1 inhibitors and use thereof |
| 09/02/2004 | WO2004073700A1 Composition comprising cysteamine for improving immunity of animals |
| 09/02/2004 | WO2004073613A2 A medicine and food |
| 09/02/2004 | WO2004073595A2 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 09/02/2004 | WO2004062551A3 RECOMBINANT VHH SINGLE DOMAIN ANTIBODY FROM CAMELIDAE AGAINST VON WILLEBRAND FACTOR (vWF) OR AGAINST COLLAGEN |
| 09/02/2004 | WO2004022657A3 Increasing of the resorption of substances via skin and mucous membranes |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | WO2004002421A3 Method for the treatment of multiple sclerosis |
| 09/02/2004 | WO2003101375A3 Immunostimulatory oligonucleotides and uses thereof |
| 09/02/2004 | WO2003084539A3 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 09/02/2004 | WO2003015697A3 Interleukin-2 mutants with reduced toxicity |
| 09/02/2004 | US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171803 Artificial protein having potentiated immunogenicity of epitope |
| 09/02/2004 | US20040171695 Guanylhydrazones useful for treating diseases associated with T cell activation |
| 09/02/2004 | US20040171635 Novel tropane esters and methods for producing and using them |
| 09/02/2004 | US20040171627 quinazolinone derivatives, especially halofuginone, can also inhibit the pathophysiological processes of renal fibrosis in vivo, including the effect on both the glomeruli and the tubuli interstitial compartments |
| 09/02/2004 | US20040171623 thieno[2,3-d]pyrimidinediones; modulation of autoimmune disease |
| 09/02/2004 | US20040171618 Compounds as PDE IV and TNF-inhibitors |
| 09/02/2004 | US20040171617 treatment for disorders and diseases, such as chronic inflammation, tissue breakdown and cancer |
| 09/02/2004 | US20040171607 Chemical compounds |
| 09/02/2004 | US20040171597 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 09/02/2004 | US20040171594 Use of bis-acid(5-androsten-17-one-3beta-hydroxyl)diester for manufacture pharmaceuticals |
| 09/02/2004 | US20040171581 Polysaccharidic esters of retinoic acid |
| 09/02/2004 | US20040171557 treating or educating said cells ex vivo in the presence of: intermediary metabolite; antigens or epitopes associated with said disease, or the immune-mediated inflammatory response; re-administering to said subject said treated or educated cells |
| 09/02/2004 | US20040171553 Peptides fragments of colostrinin and their use |
| 09/02/2004 | US20040171551 which binds to an amino acid sequence comprising at least 5 EP motifs over a 19 amino acid segment |
| 09/02/2004 | US20040171528 Raise intracellular or extracellular or serum level of metabolite in subject |
| 09/02/2004 | US20040171527 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 09/02/2004 | US20040171526 Raise intracellular or extracellular or serum level of metabolite in subject |
| 09/02/2004 | US20040171523 Immunogenic glycopeptides, screening, preparation and uses |
| 09/02/2004 | US20040171522 Raise the intracellular or extracellular or serum level of metabolite in subject |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171116 Recombinant protein variants |
| 09/02/2004 | US20040171090 Screening for cytotoxic t-lymphocyte recognition antigen associated with human t-cell leukemia virus infected cells for diagnosing and prognosing inflammation and cell proliferation disorders |
| 09/02/2004 | US20040171012 Nucleic acid-associated proteins |
| 09/02/2004 | US20040170999 Nuclear hormone receptor ligand binding domain |
| 09/02/2004 | US20040170997 used in drug screening for preventing or treating diseases associated with abnormalities in intracellular signal transduction; genetic engineering |
| 09/02/2004 | US20040170995 for drug screening in vitro for mitogen-activated protein kinase-activated protein kinase-2 modulators using expression libraries; genetic engineering; kits |
| 09/02/2004 | US20040170972 comprises DNA vaccine, a recombinant vaccine, and a T cell epitope vaccine; includes use of serological diagnosis; genetic engineering |
| 09/02/2004 | US20040170961 for drug screening anticancer agents; solid phase synthesis; animal models; genetic engineering; kits |
| 09/02/2004 | US20040170712 Applying a Jojoba oil extruded from Jojoba seeds |
| 09/02/2004 | US20040170711 Medical effect of Jojoba oil in the treatment of anal diseases |
| 09/02/2004 | US20040170710 Treating vaginal diseases by applying Jojoba oil extruded from Jojoba seeds |
| 09/02/2004 | US20040170701 Pharmaceutical composition comprising copper, salicylic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infection |
| 09/02/2004 | US20040170690 Tablet comprising cetirizine and pseudoephedrine |
| 09/02/2004 | US20040170642 Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof |
| 09/02/2004 | US20040170635 administering an inhibitor of the CD2/LFA-3 interaction, in combination with narrow band UVB radiation; especially for treating psoriasis |
| 09/02/2004 | US20040170623 having a concentration of at least 50 mg/ml of the antibody and containing an acidic component; nasal sprays and slow release formulations drying or freeze-drying |
| 09/02/2004 | US20040170620 Selected antibody compositions for binding to aminophospholipids |
| 09/02/2004 | US20040170573 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 09/02/2004 | US20040170569 Dosage forms that rapidly produces peak plasma concentrations; heating a thin layer of the drug on a solid support to form a vapor; and passing air through the heated vapor to produce aerosol particles having less than 10% drug degradation products |
| 09/02/2004 | CA2515610A1 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 09/02/2004 | CA2515434A1 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 09/02/2004 | CA2515398A1 Idiotypic vaccine |
| 09/02/2004 | CA2514485A1 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 09/01/2004 | EP1452542A2 Reshaped human monoclonal antibodies specific for IgE |
| 09/01/2004 | EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
| 09/01/2004 | EP1452522A2 Novel compounds and compositions as protease inhibitors |
| 09/01/2004 | EP1452521A1 Cyclic compound and ppar agonist |
| 09/01/2004 | EP1452181A1 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 09/01/2004 | EP1451571A2 Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same |
| 09/01/2004 | EP1451333A2 Ul16 binding protein 4 |